Host cell-type and pathogen-specific immunomodulatory functions of macrophage migration inhibitory factor (MIF) in infectious keratitis

被引:2
|
作者
Ghosh, Swagata [1 ]
Khathun, A. H. Humera [1 ]
Athulya, G. S. [1 ]
Vignesh, P. [1 ]
Mathan, L. [2 ]
Mudaraddi, Ninad [3 ]
Narendran, Siddharth [1 ,4 ]
Lalitha, Prajna [5 ]
Prajna, N. Venkatesh [3 ]
机构
[1] Aravind Med Res Fdn, Dept Microbiol, Madurai, India
[2] Aravind Med Res Fdn, Dept Prote, Madurai, India
[3] Aravind Eye Hosp, Dept Cornea & Refract Surg, Madurai, India
[4] Aravind Eye Hosp, Coimbatore, India
[5] Aravind Eye Hosp, Dept Ocular Microbiol, Madurai, India
关键词
Infectious keratitis; Inflammatory response; Immunomodulation; Macrophage migration inhibitory factor; Aspergillus flavus; Acanthamoeba castellanii; Corneal infection; ASPERGILLUS-FUMIGATUS CONIDIA; CORNEAL EPITHELIAL-CELLS; ACANTHAMOEBA-KERATITIS; IMMUNE-RESPONSE; INNATE IMMUNITY; POTENTIAL ROLE; IN-VITRO; IDENTIFICATION; DIAGNOSIS; FUSARIUM;
D O I
10.1016/j.exer.2023.109669
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Therapeutic management of inflammation in infectious keratitis (IK) requires new strategy and targets for selective immunomodulation. Targeting host cell-type specific inflammatory responses might be a viable strategy to curtail unnecessary inflammation and reduce tissue damage without affecting pathogen clearance. This study explores the possibility of pathogen and host cell-type dependent differences in the inflammatory pathways relevant in the pathogenesis of IK. Human corneal epithelial cell line (HCEC) and phorbol 12-myristate-13 acetate (PMA) differentiated THP-1 macrophage line were infected with either Aspergillus flavus conidia or Acanthamoeba castellanii trophozoites and the elicited inflammatory responses were studied in terms of gene expression and secretion of proinflammatory factors interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) and an upstream inflammatory regulator and mediator protein-the Macrophage Migration Inhibitory Factor (MIF). Given the pleotropic mode of MIF function in diverse cell types relevant in many human diseases, we tested if MIF driven responses to infection is different in HCECs and THP-1 macrophages by studying its expression, secretion and involvement in inflammation by siRNA mediated knockdown. We also examined IK patient tear samples for MIF levels. Infection with A. flavus or A. castellanii induced IL-8 and TNF-alpha responses in HCECs and THP-1 macrophages but to different levels. Our preliminary human data showed that the level of secreted MIF protein was elevated in IK patient tear, however, MIF secretion by the two cell types were strikingly different in-vitro, under both normal and infected conditions. We found that HCECs released MIF constitutively, which was significantly inhibited with infection, whereas THP-1 macrophages were stimulated to release MIF during infection. MIF gene expression remained largely unaffected by infection in both the cell lines. Although MIF in HCECs appeared to be intracellularly captured during infection, MIF knockdown in HCECs associated with a partial reduction of the IL-8 and TNF-alpha expression produced by either of the pathogens, suggesting a proinflammatory role for MIF in HCECs, independent of its canonical cytokine like function. In contrast, MIF knockdown in THP-1 macrophages accompanied a dramatic increase in IL-8 and TNF-alpha expression during A. castellanii infection, while the responses to A. flavus infection remained unchanged. These data imply a host cell-type and pathogen specific distinction in the MIF- related inflammatory signaling and MIF as a potential selective immunomodulatory target in infectious keratitis.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria
    Awandare, GA
    Hittner, JB
    Kremsner, PG
    Ochiel, DO
    Keller, CC
    Weinberg, JB
    Clark, IA
    Perkins, DJ
    CLINICAL IMMUNOLOGY, 2006, 119 (02) : 219 - 225
  • [42] Macrophage Migration Inhibitory Factor (MIF) promotes TH17 cell-driven psoriasiform dermatitis
    Bezdek, S.
    Mousavi, S.
    Hadenah, A. M.
    Zillikens, D.
    Bucala, R.
    Sadik, C. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S205 - S205
  • [43] Macrophage migration inhibitory factor (MIF) promotes TH17 cell-driven psoriasiform dermatitis
    Bezdek, S.
    Mousavi, S.
    Zillikens, D.
    Bucala, R.
    Sadik, C.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E60 - E60
  • [44] Endothelial Cell Secreted Macrophage Migration Inhibitory Factor (mif) Regulates Pericyte Contractility To Decrease Barrier Function
    Pellowe, A. S.
    Sauler, M.
    Liu, R.
    Harris, M. R.
    Calderon, B.
    Zhang, Y.
    Pober, J. S.
    Bucala, R.
    Lee, P. J.
    Gonzalez, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Different influence of macrophage migration inhibitory factor (MIF) in signal transduction pathway of various T cell subsets
    Kitaichi, N
    Ogasawara, K
    Iwabuchi, K
    Nishihira, J
    Namba, K
    Onoé, K
    Konishi, J
    Kotake, S
    Matsuda, H
    Onoé, K
    IMMUNOBIOLOGY, 2000, 201 (3-4) : 356 - 367
  • [46] Macrophage Migration Inhibitory Factor (MIF) enhances proliferation and expression of tumorigenic cytokines in a bladder cancer cell line
    Choudhary, Shilpa
    Pruitt, James R.
    Sielecki, Thais M.
    Pilbeam, Carol
    Taylor, John Arthur
    CANCER RESEARCH, 2012, 72
  • [47] Role of macrophage migration inhibitory factor (MIF) on mesenchymal stromal cell (MSC) therapeutic efficacy in acute lung injury
    Hawthorne, Ian
    Tunstead, Courteney
    Volkova, Evelina
    Dunbar, Hazel
    dos Santos, Claudia C.
    Laffey, John G.
    English, Karen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 895 - 895
  • [48] SERUM MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) LEVEL PREDICTS ACUTE CHEST SYNDROME IN PATIENTS WITH SICKLE CELL DISEASE
    Ahmed, Rafat
    Linge, Helena
    Vanan, Issai
    Apollonsky, Nataly
    Miller, Edmund
    Vlachos, Adrianna
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 832 - 833
  • [49] Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes
    Kleemann, R
    Mischke, R
    Kapurniotu, A
    Brunner, H
    Bernhagen, J
    FEBS LETTERS, 1998, 430 (03): : 191 - 196
  • [50] Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)
    Wallace, Daniel J.
    Figueras, Florence
    Wegener, William A.
    Goldenberg, David M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 954 - 955